Dicyclohexylcarbodiimide → HCID 10394325, compound
Reaction equation
[CH3:1][C:2]([CH3:34])([O:4][C:5]([C@H:7]([NH:25][C@H:26]([C:31]([OH:33])=O)[CH2:27][CH:28]([CH3:30])[CH3:29])[CH2:8][CH2:9][N:10]1[C:18](=[O:19])[C:17]2[CH:16]=[C:15]3[CH:20]=[CH:21][CH:22]=[CH:23][C:14]3=[CH:13][C:12]=2[C:11]1=[O:24])=[O:6])[CH3:3].OC1C2N=N[NH:41]C=2C=CC=1.NC[CH2:47][C:48]1[CH:53]=[CH:52][C:51]([S:54]([NH2:57])(=[O:56])=[O:55])=[CH:50][CH:49]=1.C1(N=C=NC2CCCCC2)CCCCC1>ClCCl.O.CN(C=O)C>[CH3:3][C:2]([O:4][C:5](=[O:6])[C@H:7]([NH:25][C@H:26]([C:31]([NH:41][CH2:47][C:48]1[CH:53]=[CH:52][C:51]([S:54](=[O:56])(=[O:55])[NH2:57])=[CH:50][CH:49]=1)=[O:33])[CH2:27][CH:28]([CH3:29])[CH3:30])[CH2:8][CH2:9][N:10]1[C:11](=[O:24])[C:12]2[CH:13]=[C:14]3[CH:23]=[CH:22][CH:21]=[CH:20][C:15]3=[CH:16][C:17]=2[C:18]1=[O:19])([CH3:34])[CH3:1]Participants
8
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
100 mg of N-[(R)-1-[(1,1-dimethylethoxy)carbonyl]-3-(1,3-dihydro-1,3-dioxo-2H-benz[f]isoindol-2-yl)propyl]-L-leucine, prepared as in Example L, was added to 0.8 mL DMF. 39 mg of hydroxybenzotriazol.H2O was added to the mixture followed by 57 mg of 4-aminoethylbenzenesulfonamide, 0.03 mL of N-methyl-4-morpholine, and 53 mg of dicyclohexylcarbodiimide. The mixture was stirred 72 h, and diluted with dichloromethane. The solvents were removed by evaporation and the resulting solid was purified by reverse phase H.P.L.C. The solvents were removed by lyopholization to give the title compound as a white solid; 104 mg.
Workup
- customThe solvents were removed by evaporation
- customthe resulting solid was purified by reverse phase H.P.L.C
- customThe solvents were removed by lyopholization
Sources & evidence
- ORD record
- ord-f6a2b2f1f9874c4d9258a8d0a9086274
- Source dataset
- uspto-grants-1994_07
- Patent number
- US05326760
Reaction notes
Loading…